Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Health Beat the Market Today

By Eric Volkman – Oct 6, 2021 at 5:37PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A new product launch and a fresh stock buy by a high-profile ETF lifted the telemedicine leader.

What happened

Teladoc Health (TDOC 0.48%) was a sprightly stock on Wednesday. The current top dog in the telehealth segment inched 1.6% higher -- certainly not among the company's biggest pops, but good enough to outpace the S&P 500 index on the day. Two developments seemed to be responsible for the rise.

So what

The first, and likely the most impactful, was Teladoc's announcement that it was launching a new service. On Wednesday morning, the company said that its Primary360 is now available to entities in the healthcare ecosystem, including commercial health insurance plans and the companies that utilize them.

Elderly man using telemedicine services.

Image source: Getty Images.

As the name implies, the new offering is a primary care service, and it is meant to fill a gaping hole in the healthcare landscape. Teladoc said that its experience during the pilot phase of the service showed that two-thirds of its members did not make use of primary care, which is considered essential as a means for people to monitor their health and tackle any issues as soon as possible.

Meanwhile, one of Wall Street's current star investors, Cathie Wood, opened up her checkbook to buy another batch of Teladoc stock. On Wednesday, it was revealed that on Tuesday, her ARK Innovation ETF (ARKK -1.45%) purchased 154,175 shares. That added to its existing position to give the fund a total of more than 9.1 million Teladoc shares.

In terms of total market value ($1.3 billion) and weight in the portfolio (nearly 5.8%), Teladoc is the No. 2 holding in the ARK Innovation ETF behind electric vehicle king Tesla.

Now what

Teladoc didn't provide any estimates as to how Primary360 might impact its financial results, although we can imagine customer take-up will be robust for such an important service. Meanwhile, I should caution, as usual, that no investor should pull the trigger on a stock simply because a high-profile financier has done so, although the latest ARK Innovation ETF move is certainly encouraging.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health and Tesla. The Motley Fool has a disclosure policy.

Stocks Mentioned

Teladoc Health Stock Quote
Teladoc Health
$27.22 (0.48%) $0.13
Tesla Stock Quote
$179.05 (3.23%) $5.61
Ark ETF Trust - Ark Innovation ETF Stock Quote
Ark ETF Trust - Ark Innovation ETF
$34.65 (-1.45%) $0.51

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.